Anti-hyperglycemic activity of chromium(III) malate complex in alloxan-induced diabetic rats

Biological Trace Element Research

Volumn 143, Issue 2, 2011, Pages 1031-1043

  Wu, Xiang Yang ^a   Li, Fang ^a   Xu, Wei Dong ^a   Zhao, Jiang Li ^a   Zhao, Ting ^a   Liang, Ling Hong ^a   Yang, Liu Qing ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

Acute toxicity; Anti hyperglycemic activity; Chromium complex; Diabetes; L malic acid; Synthesis

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; CHOLESTEROL; CHROMIUM MALATE COMPLEX; GLIBENCLAMIDE; GLUCOSE; GLYCOGEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTI HYPERGLYCEMIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CHELATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DNA DAMAGE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG SYNTHESIS; GLYCOGEN LIVER LEVEL; NONHUMAN; RAT; SPECTROSCOPY; THERMODYNAMICS; TOXICITY TESTING; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; CHROMIUM COMPOUNDS; DIABETES MELLITUS, EXPERIMENTAL; DNA DAMAGE; FEMALE; HYPOGLYCEMIC AGENTS; LIVER GLYCOGEN; MALE; RATS; TRIGLYCERIDES;

RATTUS;

EID: 80054726907     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-010-8916-6     Document Type: Article

References (30)

1. D Ghosh B Bhattacharya B Mukherjee, et al. 2002 Role of chromium supplementation in Indians with type 2 diabetes mellitus J Nutr Biochem 13 690 697 12550067 10.1016/S0955-2863(02)00220-6 1:CAS:528:DC%2BD38XoslGhurw%3D
2. BW Morris S Kouta R Robinson, et al. 2000 Chromium supplementation improves insulin resistance in patients with Type 2 diabetes mellitus Diabet Med 17 684 685 11051290 10.1046/j.1464-5491.2000.00342.x 1:STN:280: DC%2BD3crgt1yntQ%3D%3D
3. HG Preuss B Echard NV Perricone, et al. 2008 Comparing metabolic effects of six different commercial trivalent chromium compounds J Inorg Biochem 102 1986 1990 18774175 10.1016/j.jinorgbio.2008.07.012 1:CAS:528:DC%2BD1cXht1ensLbF
4. RA Anderson 1997 Chromium as an essential nutrient for humans Regul Toxicol Pharmacol 26 S35 S41 10.1006/rtph.1997.1136 1:CAS:528:DyaK2sXms12rur0%3D
5. K Sahina M Ondercib M Tuzcuc, et al. 2007 Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat Metab Clin Exp 56 1233 1240 10.1016/j.metabol.2007.04.021
6. JB Vincent 2001 The bioinorganic chemistry of chromium(III) Polyhedron 20 1 26 10.1016/S0277-5387(00)00624-0 1:CAS:528:DC%2BD3MXpvFOhsg%3D%3D
7. M Vrtovec B Vrtovec A Briski, et al. 2005 Chromium supplementation shortens QTc interval duration in patients with type 2 diabetes mellitus Am Heart J 149 632 636 15990745 10.1016/j.ahj.2004.07.021 1:CAS:528: DC%2BD2MXjtVyltbY%3D
8. S Besong JA Jackson DS Trammell, et al. 2001 Influence of supplemental chromium on concentrations of liver triglyceride, blood metabolites and rumen VFA profile in steers fed a moderately high fat diet J Dairy Sci Sci 84 1679 1685 10.3168/jds.S0022-0302(01)74603-6 1:CAS:528:DC%2BD3MXlvFamu7g%3D
9. DM Stallings DDD Hepburn M Hannah, et al. 2006 Nutritional supplement chromium picolinate generates chromosomal aberrations and impedes progeny development in Drosophila melanogaster Mutat Res 610 101 113 16887379 1:CAS:528:DC%2BD28XhtVGhsrzN
10. MA Andersson V Petersson Grawe Kierstin OM Karlsson, et al. 2007 Evaluation of the potential genotoxicity of chromium picolinate in mammalian cells in vivo and in vitro Food Chem Toxicol 45 1097 1106 17418471 10.1016/j.fct.2006.11.008 1:CAS:528:DC%2BD2sXksV2qtr0%3D
11. DDD Hepburn J Marcel Burney SA Woski, et al. 2003 The nutritional supplement chromium picolinate generates oxidative DNA damage and peroxidized lipids in vivo Polyhedron 22 455 463 10.1016/S0277-5387(02)01369-4 1:CAS:528:DC%2BD3sXms1eiug%3D%3D
12. E Król Z Krejpcio 2010 Chromium(III) propionate complex supplementation improves carbohydrate metabolism in insulin-resistance rat model Food Chem Toxicol 48 2791 2796 20633590 10.1016/j.fct.2010.07.008
13. H Staniek M Kostrzewska-Poczekaj M Arndt, et al. 2010 Genotoxicity assessment of chromium(III) propionate complex in the rat model using the comet assay Food Chem Toxicol 48 89 92 19770020 10.1016/j.fct.2009.09.020 1:CAS:528:DC%2BD1MXhs1WntrzJ
14. H Staniek Z Krejpcio K Iwanik 2010 Evaluation of the acute oral toxicity class of tricentric chromium(III) propionate complex in rat Food Chem Toxicol 48 859 864 20036299 10.1016/j.fct.2009.12.022 1:CAS:528:DC%2BC3cXit1Ortb4%3D
15. V Bobyleva-Guarriero RS Wehbie HA Lardy 1986 The role of malate in hormone-induced enhancement of mitochondrial respiration Arch Biochem Biophys 245 477 482 3954365 10.1016/0003-9861(86)90240-7 1:CAS:528:DyaL28Xht1ertLc%3D
16. JL Wu QP Wu XF Yang, et al. 2008 L-malate reverses oxidative stress and antioxidative defenses in liver and heart of aged rats Physiol Res 57 261 268 17298203 1:CAS:528:DC%2BD1cXptVWgs7c%3D
17. NMG Deburgos F Gallina C Burgos, et al. 1994 Effect of L-malate on pyruvate-dehydrogenase activity of spermatozoa Arch Biochem Biophys 308 520 524 10.1006/abbi.1994.1073
18. SA Nair BS Shylesh B Gopakumar, et al. 2006 Anti-diabetes and hypoglycaemic properties of Hemionitis arifolia (Burm.) Moore in rats J Ethnopharmacol 106 192 197 10.1016/j.jep.2005.12.020
19. G Buccolo M David 1973 Quantitative determination of serum triglycerides by use of enzyme Clin Chem 19 476 482
20. NV Carroll RW Longly HR Joseph 1956 Determination of glycogen in liver and muscle by use of anthrone reagent J Biol Chem 220 583 593 13331917 1:CAS:528:DyaG28XmvF2juw%3D%3D
21. B Hallwell JM Gutteridge OI Aruoma 1987 The deoxyribose method: a simple "test-tube" assay for determination of rate constants for reactions of hydroxyl radicals Anal Biochem 165 215 219 10.1016/0003-2697(87)90222-3
22. JE Hilaly ZH Israili B Lyoussi 2004 Acute and chronic toxicological studies of Ajuga iva in experimental animals J Ethnopharmacol 91 43 50 15036466 10.1016/j.jep.2003.11.009
23. Abdel-Monem MM, Mahamoud M, Anderson MD (2003) Novel chromium(III) alpha amino acid complexes. US patent: 0030228394
24. 3 improves insulin responsiveness and reduces whole body glucose tolerance FEBS Lett 579 1458 1464 15733857 10.1016/j.febslet.2005.01.049 1:CAS:528:DC%2BD2MXhslCisrs%3D
25. D-S Kim T-W Kim I-K Park, et al. 2002 Effects of chromium picolinate supplementation on insulin sensitivity, serum lipids, and body weight in dexamethasone-treated rats Metabolism 51 589 594 11979390 10.1053/meta.2002. 31985 1:CAS:528:DC%2BD38XjsFakt7k%3D
26. A-K Bordbar AL Creagh F Mohammadi, et al. 2009 Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin J Inorg Biochem 103 643 647 19056126 10.1016/j.jinorgbio.2008.10.009 1:CAS:528:DC%2BD1MXjsFansLw%3D
27. 3 J Inorg Biochem 100 1187 1193 16545457 10.1016/j.jinorgbio.2006.01.039 1:CAS:528:DC%2BD28Xltl2iu7Y%3D
28. JB Vincent 2004 Recent advances in the nutritional biochemistry of trivalent chromium Proc Nutr Soc 63 41 47 15070438 10.1079/PNS2003315 1:CAS:528:DC%2BD2cXktFGlurs%3D
29. DD Hepburn JB Vincent 2002 In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement Chem Res Toxicol 15 93 100 11849034 10.1021/tx010091t 1:CAS:528: DC%2BD38XhvFOnsw%3D%3D
30. GV Alexeeff R Broadwin J Liaw, et al. 2002 Characterization of the LOAEL-to-NOAEL uncertainty factor for mild adverse effects from acute inhalation exposures Regul Toxicol Pharmacol 36 96 105 12383722 10.1006/rtph.2002.1562 1:CAS:528:DC%2BD38Xntlygsbc%3D